Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,230.00
+275.00 (5.55%)
Mar 20, 2026, 3:30 PM KST
Market Cap321.86B -20.1%
Revenue (ttm)96.80B +81.0%
Net Income16.05B -9.8%
EPS237.82 -22.0%
Shares Out61.54M
PE Ratio21.99
Forward PEn/a
Dividend50.00 (1.01%)
Ex-Dividend DateDec 29, 2025
Volume416,906
Average Volume416,288
Open4,955.00
Previous Close4,955.00
Day's Range4,945.00 - 5,240.00
52-Week Range4,510.00 - 8,420.00
Beta0.50
RSI54.19
Earnings DateMar 27, 2026

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2003
Employees 147
Stock Exchange KOSDAQ
Ticker Symbol 099430
Full Company Profile

Financial Performance

In 2024, Bio Plus's revenue was 66.41 billion, an increase of 2.10% compared to the previous year's 65.04 billion. Earnings were 14.15 billion, a decrease of -44.68%.

Financial Statements